Physician profile
Jun Kim
NPI 1073546024
$2,816.51
in general payments reported to CMS, 2019-2025
18 companies · $634 in 2025
The $634 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $400 · 2022: $495 · 2023: $716 · 2024: $572 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,779 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,778.52 |
| Education | $142.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $924.34 | 2021-2025 | Dupixent |
| Genzyme Corporation | $513.84 | 2021-2025 | |
| Glaxosmithkline, LLC. | $266.85 | 2021-2025 | Nucala |
| Optinose US, INC. | $226.00 | 2021-2025 | |
| Cardiva Medical, INC. | $138.44 | 2021-2024 | Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals Lp | $134.55 | 2025 | |
| Sirtex Medical INC | $118.56 | 2022 | |
| Boston Scientific Corporation | $117.21 | 2023 | |
| Kaleo, INC. | $88.03 | 2021-2023 | Auvi-Q |
| Alk-Abello, INC | $65.21 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $60.21 | 2022-2024 | Ryaltris |
| Acelrx Pharmaceuticals, INC. | $47.09 | 2021-2022 | |
| Medtronic, INC. | $24.95 | 2024 | Sinuva |
| Intersect Ent, INC. | $23.16 | 2021 | |
| Merck Sharp & Dohme LLC | $21.10 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.80 | 2024 | Ent Sinus |
| Phadia US INC. | $15.14 | 2021 | |
| Aytu Biopharma, INC. | $15.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.